SLC11A2 and central nervous system cancer: The in vitro findings supported the hypothesis, as treatment with (R, S)-AMPA increased DMT1 expression following CPAR expression upregulation, suggesting that CPARs may be involved in the upstream regulation of DMT1 in glioma cells.